# CORRESP — GRI Bio, Inc.  (GRI)  (CIK 0001824293)

> <strong>GRI Bio, Inc.  (GRI)  (CIK 0001824293) → SEC staff</strong> · filed 2025-12-09 · ticker GRI · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001628280-25-056216
- **Form:** CORRESP
- **Filer:** GRI Bio, Inc.  (GRI)  (CIK 0001824293)
- **CIK:** 0001824293
- **Ticker:** GRI
- **Filed:** 2025-12-09
- **SIC industry:** 2834
- **HQ:** La Jolla, CA

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1824293/000162828025056216/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1824293&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for GRI Bio, Inc.  (GRI)  (CIK 0001824293)

- UPLOAD — 2026-01-30 — /comment-letter/0000000000-26-001119
- CORRESP — 2026-01-30 — /comment-letter/0001824293-26-000036
- CORRESP — 2025-12-09 — /comment-letter/0001628280-25-056217

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, GRI Bio, Inc.  (GRI)  (CIK 0001824293) (CIK 0001824293), filed 2025-12-09, accession 0001628280-25-056216. Retrieved via MORVS 2026-11-03 from https://api.morvs.ai/comment-letter/0001628280-25-056216.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*